Benlysta, GlaxoSmithKline's treatment for autoimmune disease lupus has been recommended by NICE, after the company agreed to a price cut and a real world data study. The decision comes after years ...
Abdominal pain is a common yet complex symptom for people with lupus, often caused by inflammation or side effects of medication. This pain may vary from mild digestive issues to more serious ...
Among 1,029 lupus patients in high disease activity status ... 95% CI 0.20-0.52); 12 months of LDAS cut that risk by another third (HR 0.22, 95% CI 0.09-0.56), compared with those never achieving ...
IGM Biosciences has decided to halt development of imvotamab and IGM-2644, two IgM-based bispecific antibody T cell engagers for autoimmune diseases, and cut its staff by 73%. The biotechnology ...